Smith & Nephew

Select your country

Advanced Search

  • Home
  • About Us
  • Innovation
  • Corporate Responsibility
  • Investor Centre
  • News & Media
  • Careers
  • Home
  • About Us
  • Who we are
  • Our Board
  • Home >
  • About Us >
  • Who we are >
  • Our Board
  • Our History
  • Executive Management
  • Our Board
  • Print
  • e-mail

Email this page

close
  1. Mandatory fields are marked with an asterisk [*].

    Tell us who you want to send your mail to Fill in your email details

    Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.

    Change your message if you want Change the message if you want to

    1. <recipient name> <address>
    2. <sender name> <address>
    3. <sender name> is sending you a link

    4. <sender name>

Our Board

  • Click here to contact us

John Buchanan

Chairman

OurBoard_JohnBuchanan

Age 64
He was appointed independent non-executive Deputy Chairman in 2005 and became Chairman in April 2006. He is Chairman of the Nominations Committee. He is Deputy Chairman of Vodafone Group Plc and a non-executive director of AstraZeneca PLC and BHP Billiton. He was formerly Group Chief Financial Officer of BP p.l.c.

David Illingworth

Chief Executive

OurBoard_DavidIllingworth_ChiefExecutive

Age 54
He joined the Group in May 2002 as President of Orthopaedics and was appointed a director and Chief Operating Officer in February 2006. Appointed Chief Executive from 1 July 2007.  Prior to joining the Group he held posts within GE Medical, as Chief Executive Officer of a publicly traded medical devices company, President of a respiratory/critical care company and President of a technology incubator company.

Adrian Hennah

Chief Financial Officer

Our Board_chief_financial officer_Adrian Hennah

Age 50
He joined the Group and was appointed a director in June 2006. He was previously Chief Financial Officer of Invensys plc and held various senior positions within GlaxoSmithKline.

Brian Larcombe

Non-Executive Director

OurBoard_BrianLarcombe_Non-ExecutiveDirector

Age 54
He was appointed a director in March 2002 and is a member of the Audit Committee. He is a non-executive director of F&C Asset Management plc and Chairman of Bramdean Alternatives Limited. Previously he was Chief Executive Officer of 3i Group plc.

Pam Kirby

Non-Executive Director

OurBoard_Pam Kirby_Non-Executive_Director

Age 54

She was appointed a director in March 2002 and is a member of the Remuneration Committee and the Ethics and Compliance Committee. She is non-executive Chairman of Scynexis Inc and a non-executive director of Informa plc, Curalogic A/S and Novo Nordisk A/S..


 

Richard De Schutter

Non-Executive Director

OurBoard_RichardDeSchutter_Non-Executive_Director

Age 67
He was appointed a director in January 2001. He is Chairman of the Ethics and Compliance Committee and is a member of the Audit Committee and the Remuneration Committee. He is non-executive Chairman of Incyte Corporation and a non-executive director of Varian Inc., MedPointe Pharmaceuticals, Ecolab Inc and Navicure Inc.

Rolf Stomberg

Non-Executive Director

OurBoard_RolfStomberg_Non-Executive_Director

Age 67
He was appointed a director in 1998 and is Chairman of the Remuneration Committee and a member of the Audit Committee and Nominations Committee. He is Chairman of Francotyp - Postalia AG and Lanxess AG and a non-executive director of Reed Elsevier plc, Hoyer GmbH, TNT N.V., Deutsche BP AG, Biesterfeld AG and Severstal.

Warren Knowlton

Non-Executive Director

OurBoard_WarrenKnowlton_Non-ExecutiveDirector

Age 61
He was appointed a director in November 2000 and is Chairman of the Audit Committee and a member of the Remuneration Committee. He is Chairman and Chief Executive Officer of Graham Packaging Inc. and a non-executive director of Ameriprise Financial Inc. Previously he was Group Chief Executive of Morgan Crucible plc.

Joseph Papa

Non-Executive Director

j papa

Age 52
He was appointed a director in August 2008 and is a member of the Ethics and Compliance Committee. He is Chairman of Perrigo Company, a leading global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products.

  • Copyright © 2008 Smith & Nephew
  • Terms of Use